11/03/2024, 12:06 PM UTC
财报后，辉瑞是一家值得买入的好股票Pfizer Is A Good Stock To Buy After The Earnings
1. 辉瑞在收入和利润方面均超过了分析师的预期，并提高了全年指引。2. 由于增长的主要部分是由与COVID-19相关的产品或非经常性项目驱动的，投资者对财报的反应并不积极。3. 根据单阶段股息折现模型和传统市盈率等指标，PFE似乎被低估，表明当前股价水平可能是启动头寸的有吸引力的水平。1. Pfizer has exceeded analyst estimates on both top and bottom lines and raised its full-year guidance. 2. Investors have not responded positively to the earnings news due to the significant portion of growth being driven by Covid-19 related products or non-recurring items. 3. Based on a single stage dividend discount model and traditional price multiples, PFE appears undervalued, suggesting the current price level could be attractive for initiating a position.
---
本文由大语言模型（LLM）生成，旨在为读者提供半导体新闻内容的知识扩展（Beta）。
